| This week's sponsor is Roquette. | |  | Roquette - The Biological Choice
Sole custody of our supply chain ensures a safe, secure and reliable supply of quality raw materials and excipients. Trust Roquette for all your biopharma needs. Learn more. |
Featured Story Friday, April 21, 2017  The European Medicines Agency’s (EMA) drug approval committee has indicated it is likely to reject XBiotech’s metastatic colorectal cancer candidate when it holds a formal vote next month. Shares in XBiotech slumped following the news.
| This week's sponsor is Sensors Expo & Conference 2017. | |  | |
Top Stories Friday, April 21, 2017 Gilead Sciences has unveiled the first proof-of-concept data for its novel drug candidate for nonalcoholic steatohepatitis (NASH) as it tries to rebuild confidence in its R&D pipeline. Friday, April 21, 2017 The FDA has knocked back Vernalis’ filing for approval of CCP-07. The setback wiped 12% off Vernalis’ stock price in early trading as investors weighed the impact of the at-best-delayed approval of a cough-cold drug projected to generate peak sales of $150 million (€140 million) to $500 million. Thursday, April 20, 2017 Stanford University scientists have identified a protein that, given before an injury, boosts stem cell response and improves healing. “Priming” with this protein could eventually speed recovery in cases where injury is expected, such as patients undergoing surgery. Thursday, April 20, 2017 In this week's EuroBiotech Report, EU crushes U.K.’s EMA hopes, Roche shares look at hemophilia A data, Circassia fails again and more. Friday, April 21, 2017 Novartis' CEO said China's pharma market will surpass $300 billion by 2020, Hanmi was found breaking two medical laws when it failed to disclose olmutinib trial side effect on time, Celgene tapped Antengene as its first Asia-Pacific partner. Thursday, April 20, 2017 Juno tapped Genentech alum Sunil Agarwal as new R&D chief, Merrimack promoted Onivyde scientist Daryl Drummond as head of research, and Mitch Gold leads the newly merged and soon-to-be-public Alpine. Plus more hirings, firings and retirings throughout the industry. | This week's sponsor is J.P. Morgan Private Bank. | |  | How Pre-Transaction Planning Can Maximize Your Wealth
You've worked hard to build a successful healthcare business. To reap the rewards of a sale, merger, recap or IPO, be sure you maximize the value of your equity interests with careful pre-transaction planning. Learn how J.P. Morgan Private Bank can help you protect your wealth. Read the article. |
| | | The Medicines Patent Pool has penned a new license and tech transfer deal with Egypt's Pharco Pharmaceuticals for its pan-genotype hep C candidate ravidasvir. Release Former Monsanto and Synergy Pharmaceuticals exec Kunwar Shailubhai has been named as the new CEO at blood cancer biotech Rasna Therapeutics. Statement Bloomberg data show that biopharma M&A has yet to pick up, with pharma and biotech acquisitions just $44 billion last quarter, down 13% from a year earlier, and 35% below the first quarter of 2015. Bloomberg story | |
|
Resources Sponsored By: LMK Clinical Research Consulting Training is a vital component of workplace efficiency especially when it comes to one of the most important deliverables of a clinical trial – the Trial Master File (TMF). Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Presented By: Veeva Share your thoughts on the life sciences industry’s progress in reducing system and process complexity to improve study execution. The first 50 qualified respondents will receive a $10 Amazon gift card, as well as a $10 donation made to Doctors Without Borders in their name. Finish the survey today! Presented By: Enterprise Florida As life sciences companies decide to implement shared services, a major concern is real estate costs for a facility. Download this Whitepaper to learn why Florida is gaining traction as a prime location for shared services. |
|
